Atrial Septal Defects News and Research

RSS

New AI-based screening strategy uses ECG to detect heart defects

Researchers explore the use of artificial intelligence in enhancing the yield of conventional screening for ASDs using 12-lead electrocardiography.

21 Aug 2023

AI model can detect atrial septal defect in ECGs with high accuracy

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods.

17 Aug 2023

Prenatal diagnosis is linked to earlier surgery for babies with congenital heart defects

A study from Ann & Robert H. Lurie Children's Hospital of Chicago has shown that prenatal diagnosis, or diagnosis before a baby is born, is associated with earlier surgery for babies with congenital heart defects, the most common birth defects affecting nearly 1% of all live births.

4 Aug 2023

Updated expert consensus statement on transcatheter left atrial appendage closure released

Today, the Society for Cardiovascular Angiography & Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC).

27 Mar 2023

Structural Heart features research on ASD closure and disparities in access to Watchman device

The Cardiovascular Research Foundation is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research articles on readmissions after atrial septal defect closure and socioeconomic disparities in access to the Watchman device in patients with atrial fibrillation.

13 Mar 2019

Occlutech's Atrial Septal Defect Closure Device approved in Japan

Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained Japanese MHW approval for its dedicated Atrial Septal Defect Closure Device. The device is a specifically designed implant indicated for the minimally invasive closure of Atrial Septal Defects, ASD.

12 Jan 2016

BioSTAR biodegradable implant achieves comparable closure rates to Amplatzer ASO

A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD). The BioSTAR device displayed successful outcomes, while avoiding issues associated with implants containing substantial amounts of metal.

16 Jul 2010

Magnetically guided nanoparticles for delivering DNA, cells and drugs

Scientists and engineers have used uniform magnetic fields to drive iron-bearing nanoparticles to metal stents in injured blood vessels, where the particles deliver a drug payload that successfully prevents blockages in those vessels. In this animal study, the novel technique achieved better results at a lower dose than conventional non-magnetic stent therapy.

20 Apr 2010

Patent applications continue to alter medical landscape to improve patient care

Over the past 40 years, more than 2,400 patents and patent applications-pioneering modern medicine with the devices and drugs that advance minimally invasive treatments-have been filed by members of the Society of Interventional Radiology.

17 Mar 2010

District court of Frankfurt, Germany rules in favour of Occlutech

Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders.

24 Sep 2009

Fruit flies provide better understanding of human heart disease

Researchers at the Burnham Institute for Medical Research have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function.

3 Dec 2008

Trial of Gore-tex-type material to stop strokes

A study is under way at Rush University Medical Center using a small, soft-patch device made of a Gore-tex-type material - often used to make durable outerwear - to close a common hole found in the heart called a patent foramen ovale (PFO) in order to prevent recurrent strokes and transient ischemic attacks (TIAs) in adults.

18 Nov 2008

Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement

A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.

24 Aug 2007

Closure of holes in heart important treatment for young stroke patients

Placement of devices to close holes in the heart is a successful treatment for young stroke patients, finds a study involving three medical centers.

17 May 2006

Heart repair linked to migraine relief

Migraine headache patients reported the painful attacks eased or even vanished after they underwent procedures to close abnormalities that allow blood to flow between the atria of their hearts, according to the results of two new studies in the current issue of the Journal of the American College of Cardiology.

16 Feb 2005

Time bomb in heart leads to heart failure in some congenital heart disease patients

However, surgical correction of certain forms of congenital heart disease may not fix the underlying molecular trigger that drives progressive heart failure and sudden death later in life, according to new research from the University of California, San Diego (UCSD) School of Medicine.

29 Apr 2004